ARWRArrowhead Pharmaceuticals

Median target
$109.5
calls from the last 12 months
Implied return
+61.6%
median target vs. price
Coverage
13 analysts · 17 calls
updated in the last 12 months
Consensus
10/3/0+10 net
Buy / Hold / Sell

Which analysts are behind ARWR's consensus?

See every current rating, price target and the analysts' track records for Arrowhead Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 13 analysts with calls on ARWR updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ARWR elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-18InsidersPerry Michael SDirectorInsider sale11.6K sh @ $87.30$1.0M
2026-08-18InsidersOlukotun Adeoye YDirectorInsider sale2.0K sh @ $86.96$174K
2025-07-31ExecutiveTrump, Donald JPresidentSaleArrowhead Pharmaceuticals, Inc.$15,001 - $500,007
2025-06-30ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$15,001 - $500,006
2025-05-29ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$15,001 - $500,005
2025-04-28ExecutiveTrump, Donald JPresidentSaleArrowhead Pharmaceuticals, Inc.$50,001 - $1,000,004
2025-04-08ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$1,001 - $150,004
2025-03-27ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$1,001 - $150,003
2025-03-05ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$1,001 - $150,003
2025-02-13ExecutiveTrump, Donald JPresidentPurchaseArrowhead Pharmaceuticals, Inc.$1,001 - $150,002

More: congressional trades on ARWR · insider activity · executive branch · trending